Eukaryotic translation initiation factors and cancer

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Messenger RNA (mRNA) translation is a complex, multi-phase process vital for protein synthesis in eukaryotic cells.
• Translation regulation primarily occurs during the initiation phase, orchestrated by eukaryotic translation initiation factors (eIFs).
• eIFs are crucial for forming functional ribosomes at the start codon and controlling translation initiation.

Purpose of the Study:

• To review the role of eIFs in mRNA translation initiation.
• To explore the contribution of eIFs to cancer onset and progression.
• To discuss the potential of targeting dysregulated eIFs for cancer therapy.

Main Methods:

• Literature review of recent technological advancements and mechanistic studies.
• Analysis of the involvement of eIFs in the four phases of translation (initiation, elongation, termination, ribosome recycling).
• Examination of the link between eIFs, oncogenic/tumor suppressive genes, and tumorigenesis.

Main Results:

• eIFs play a critical role in stabilizing ribosome formation and regulating translation initiation.
• Dysregulated mRNA translation is a hallmark of cancer.
• Components of the translation machinery, particularly eIFs, are implicated in tumorigenesis.

Conclusions:

• eIFs are central regulators of mRNA translation initiation.
• Aberrant eIF function is linked to cancer development and progression.
• Targeting dysregulated eIFs presents a promising strategy for developing novel anticancer therapeutics.